Acupuncture for patients with migraine: A randomized controlled trial

JAMA

Volumn 293, Issue 17, 2005, Pages 2118-2125

  Linde, Klaus ^a   Streng, Andrea ^a   Jürgens, Susanne ^a   Hoppe, Andrea ^a   Brinkhaus, Benno ^c   Witt, Claudia ^c   Wagenpfeil, Stephan ^b   Pfaffenrath, Volker ^d   Hammes, Michael G ^a   Weidenhammer, Wolfgang ^a   Willich, Stefan N ^c   Melchart, Dieter ^a,e  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d NONE

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUPUNCTURE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GERMANY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MIGRAINE; OUTPATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACUPUNCTURE THERAPY; ADULT; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS;

EID: 17844368599     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.17.2118     Document Type: Article

References (31)

1. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence: a review of population-based studies. Neurology. 1994;44(suppl 4):S17-S23.
2. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-657.
3. Gray RN, Goslin RE, McCrory DC, Eberlein K, Tulsky J, Hasselblad V. Drug treatments for the prevention of migraine headache: technical review 2.3. 1999; Prepared for the Agency of Health Care Policy and Research. Available at: http://www.clinpol.mc.duke .edu. Accessibility verified March 31, 2005.
4. Melchart D, Linde K, Fischer P, et al. Acupuncture for recurrent headaches: a systematic review of randomized controlled trials. Cephalalgia. 1999;19:779-786.
5. Melchart D, Linde K, Streng A, et al. Acupuncture randomized trials (ART) in patients with migraine or tension-type headache-design and protocols. Forsch Komplementarmed Klass Naturheilkd. 2003;10:179-184.
6. Machin D, Campbell MJ, Payers PM, Pinol APY Sample Size Tables for Clinical Studies. 2nd ed. Oxford, England: Blackwell; 1997.
7. International Headache Society. ICH-10 guide for headaches. Cephalalgia. 1997;17(suppl 19):1-82.
8. Diener HC, Brune K, Gerber WD, Gôbel H, Pfaffenrath V. Behandlung der Migräneattacke und Migräneprophylaxe. Dt Ärztebl. 1997;94:C2277-C2283.
9. Nagel B, Gerbershagen HU, Lindena G, Pfingsten M. Entwicklung und empirische Überprüfung des Deutschen Schmerzfragebogens der DGSS. Schmerz. 2002;16:263-270.
10. Dillmann U, Nilges P, Saile E, Gerbershagen HU. Behinderungseinschä tzung bei chronischen Schmerzpatienten. Schmerz. 1994;8:100-110.
11. Geissner E. Die Schmerzempfindungsskala (SES). Göttingen, Germany: Hogrefe; 1996.
12. Hautzinger M, Bailer M. Allgemeine Depressionsskala (ADS): Die deutsche Version des CES-D. Weinheim, Germany: Beltz; 1993.
13. Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Göttingen, Germany: Hogrefe; 1998.
14. Vincent C. Credibility assessments in trials of acupuncture. Complement Med Res. 1990;4:8-11.
15. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000;20:765-786.
16. Linde K, Rossnagel K. Propranolol for migraine prophylaxis [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 2004; issue 2.
17. Diener HC, Matias-Guiu J, Hartung E, et al. Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily. Cephalalgia. 2002;22:209-221.
18. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291:965-973.
19. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? an analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344:1594-1602.
20. Sandkühler J. The organization and function of endogenous antinociceptive systems. Prog Neurobiol. 1996;50:49-81.
21. Irnich D, Beyer A. Neurobiologische Grundlagen der Akupunkturanalgesie Schmerz. 2002;16:93-102.
22. Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J Clin Epidemiol. 2000;53:786-792.
23. Kaptchuk TJ. The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Ann Intern Med. 2002;136:817-825.
24. Walach H, Jonas WB. Placebo research: the evidence base for harnessing self-healing capacities. J Altern Complement Med. 2004;10(suppl 1):S103-S112.
25. Vickers AJ, Rees RW, Zollmann CE, et al. Acupuncture for chronic headache in primary care: large, pragmatic, randomised trial. BMJ. 2004;328:744-746.
26. Wonderling D, Vickers AJ, Grieve R, McCarney R. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. BMJ. 2004;328:747-749.
27. Jena S, Becker-Wtt C, Brinkhaus B, Selim D, Willich SN. Effectiveness of acupuncture treatment for head-ache-the Acupuncture in Routine Care Study (ARC Headache). Focus Altern Complement Ther. 2004;9(suppl 1):17.
28. Hesse J, Mogelvang B, Simonsen H. Acupuncture vs metoprolol in migraine prophylaxis: a randomized trial of trigger pointinactivation. J Intern Med. 1994;235:451-456.
29. Allais G, De Lorenzo C, Quirico P, et al. Acupuncture in the prophylactic treatment of migraine without aura: a comparison with flunarizine. Headache. 2002;42:855-861.
30. Molsberger A, Diener HC, Krämer J, et al. GERAC-Akupunktur-Studien- Modellvorhaben zur beureilung der Wirksamkeit [GERAC acupuncture trials-a program to assess effectiveness]. Dt Ärztebl. 2002;99: A1819-A1824.
31. Melchart D, Streng A, Reitmayr S, Hoppe A, Weidenhammer W, Linde K. Programm zur Evaluation der Patientenversorgung mit Akupunktur (PEP-AC)-die wissenschaftliche Begleitung des Modellvorhabens der Ersatzkassen [Program to evaluate acupuncture in the German health care system (PEP-AC)-the scientific concept of the program of a group of statutory sickness funds]. Z ärztl Fortbild Qual Gesundhwes. 2004;98:471-473.